Charles River: A Fantastic Compounder Back To 2020 Prices
The Charles River thesis plus quick updates on OMAB and Roper.
Summary
A few quick hits this weekend + the detailed thesis for Charles River Laboratories.
Charles River serves as an effective tax on the entire biotech industry; it's a classic picks and shovels way to own biotech without the individual drug/FDA risk.
Company has grown earnings at a compounded 15% rate for decades and shares are now down to 20x forward …
Keep reading with a 7-day free trial
Subscribe to Ian’s Insider Corner to keep reading this post and get 7 days of free access to the full post archives.